Literature DB >> 11436192

Changes in blood lipids consequent to aerobic exercise training related to changes in body fatness and aerobic fitness.

P T Katzmarzyk1, A S Leon, T Rankinen, J Gagnon, J S Skinner, J H Wilmore, D C Rao, C Bouchard.   

Abstract

The contribution of changes in body fatness and aerobic fitness to changes in blood lipids after aerobic exercise training was investigated. The sample included 295 men (77 black, 218 white) and 355 women (131 black, 224 white), aged 17 to 65 years, from the HERITAGE Family Study. Participants underwent measurements at baseline and after 20 weeks of supervised exercise training on a cycle ergometer. Body fat mass (FM, in kilograms) was determined by underwater weighing, and aerobic fitness (maximal oxygen uptake, VO(2max), in milliliters per minute) was assessed by cycle ergometry. Blood lipid measurements included fasting plasma levels of high-density lipoprotein cholesterol (HDL-C), HDL(2)-C, HDL(3)-C, low-density lipoprotein cholesterol (LDL-C), total cholesterol (CHOL), CHOL/HDL, and triglycerides (TG). A composite lipid change index (LCI) was derived by subjecting the Delta scores for the individual blood lipids to principal components analysis. The exercise training was accompanied by a mean increase of 17.5% in VO(2max) and a mean decrease of 3.3% in FM. Partial correlations, controlled for age, between absolute changes in VO(2max) and changes in the blood lipids were consistently low and nonsignificant. On the other hand, absolute changes in FM were significantly (P <.05) associated with changes in HDL-C (r = -.23), HDL(2)-C (r = -.17), and CHOL/HDL (r =.24) and the LCI (r = -.27) in men and with changes in LDL-C (r =.22), CHOL (r =.19), and CHOL/HDL (r =.15) and the LCI (r = -.19) in women. Forward stepwise regression confirmed that the change in FM was a better predictor of changes in blood lipids than the change in VO(2max), entering as a predictor in 4 of 8 regressions in both men and women. Change in VO(2max) did not enter as a significant predictor in any regression. Further, there were no differences in LCI between the upper and lower quartiles of VO(2max) change. On the other hand, there were significant differences between the low and high quartiles of FM change. No race effects were observed in any of the relationships, except that race was a significant predictor of changes in TG in both men and women. In conclusion, changes in blood lipids associated with aerobic exercise training do not appear to be related to changes in aerobic fitness per se; rather, they are weakly to moderately associated with changes in body fatness. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11436192     DOI: 10.1053/meta.2001.24190

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  22 in total

1.  Plasma triglyceride concentrations are rapidly reduced following individual bouts of endurance exercise in women.

Authors:  Gregory C Henderson; Ronald M Krauss; Jill A Fattor; Nastaran Faghihnia; Mona Luke-Zeitoun; George A Brooks
Journal:  Eur J Appl Physiol       Date:  2010-03-09       Impact factor: 3.078

2.  Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial.

Authors:  Sara E Dolan; Walter Frontera; Jamie Librizzi; Karin Ljungquist; Sandra Juan; Robert Dorman; Morgan E Cole; Jenna R Kanter; Steven Grinspoon
Journal:  Arch Intern Med       Date:  2006-06-12

3.  Impaired muscle AMPK activation in the metabolic syndrome may attenuate improved insulin action after exercise training.

Authors:  Andrew S Layne; Sami Nasrallah; Mark A South; Mary E A Howell; Melanie P McCurry; Michael W Ramsey; Michael H Stone; Charles A Stuart
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

Review 4.  The HERITAGE Family Study: A Review of the Effects of Exercise Training on Cardiometabolic Health, with Insights into Molecular Transducers.

Authors:  Mark A Sarzynski; Treva K Rice; Jean-Pierre Després; Louis Pérusse; Angelo Tremblay; Philip R Stanforth; André Tchernof; Jacob L Barber; Francesco Falciani; Clary Clish; Jeremy M Robbins; Sujoy Ghosh; Robert E Gerszten; Arthur S Leon; James S Skinner; D C Rao; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2022-05-01

5.  Effect of exercise intensity on abdominal fat loss during calorie restriction in overweight and obese postmenopausal women: a randomized, controlled trial.

Authors:  Barbara J Nicklas; Xuewen Wang; Tongjian You; Mary F Lyles; Jamehl Demons; Linda Easter; Michael J Berry; Leon Lenchik; J Jeffrey Carr
Journal:  Am J Clin Nutr       Date:  2009-02-11       Impact factor: 7.045

6.  Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study.

Authors:  Keri L Monda; Christie M Ballantyne; Kari E North
Journal:  J Lipid Res       Date:  2009-04-03       Impact factor: 5.922

7.  Child Physical Activity Associations With Cardiovascular Risk Factors Differ by Race.

Authors:  Nicholas M Edwards; Heidi J Kalkwarf; Jessica G Woo; Philip R Khoury; Stephen R Daniels; Elaine M Urbina
Journal:  Pediatr Exerc Sci       Date:  2016-02-17       Impact factor: 2.333

8.  Chronic Exercise Reduces CETP and Mesterolone Treatment Counteracts Exercise Benefits on Plasma Lipoproteins Profile: Studies in Transgenic Mice.

Authors:  Andrea Camargo Casquero; Jairo Augusto Berti; Laura Lauand Sampaio Teixeira; Helena Coutinho Franco de Oliveira
Journal:  Lipids       Date:  2017-10-20       Impact factor: 1.880

9.  Metabolic syndrome and changes in body fat from a low-fat diet and/or exercise randomized controlled trial.

Authors:  Sarah M Camhi; Marcia L Stefanick; Peter T Katzmarzyk; Deborah R Young
Journal:  Obesity (Silver Spring)       Date:  2009-10-01       Impact factor: 5.002

Review 10.  Physical activity in obesity and metabolic syndrome.

Authors:  Barbara Strasser
Journal:  Ann N Y Acad Sci       Date:  2012-11-21       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.